DexCom (Germany) Price on October 13, 2023
DC4 Stock | EUR 73.98 0.63 0.86% |
If you're considering investing in DexCom Stock, it is important to understand the factors that can impact its price. As of today, the current price of DexCom stands at 73.98, as last reported on the 11th of December 2024, with the highest price reaching 73.98 and the lowest price hitting 73.98 during the day. DexCom appears to be very steady, given 3 months investment horizon. DexCom Inc secures Sharpe Ratio (or Efficiency) of 0.14, which denotes the company had a 0.14% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for DexCom Inc, which you can use to evaluate the volatility of the firm. Please utilize DexCom's Mean Deviation of 1.61, downside deviation of 1.46, and Coefficient Of Variation of 752.24 to check if our risk estimates are consistent with your expectations.
DexCom Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
DexCom |
Sharpe Ratio = 0.14
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | DC4 | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
2.11 actual daily | 18 82% of assets are more volatile |
Expected Return
0.3 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
0.14 actual daily | 11 89% of assets perform better |
Based on monthly moving average DexCom is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DexCom by adding it to a well-diversified portfolio.
DexCom Valuation on October 13, 2023
It is possible to determine the worth of DexCom on a given historical date. On October 13, 2023 DexCom was worth 71.33 at the beginning of the trading date compared to the closed value of 71.34. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of DexCom stock. Still, in general, we apply an absolute valuation method to find DexCom's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of DexCom where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against DexCom's related companies.
Open | High | Low | Close | Volume | |
74.60 | 74.60 | 74.60 | 74.60 | 204.00 | |
10/13/2023 | 71.33 | 71.34 | 71.33 | 71.34 | 40.00 |
72.29 | 72.29 | 72.29 | 72.29 | 40.00 |
Backtest DexCom | | | DexCom History | | | DexCom Valuation | Previous | Next |
DexCom Trading Date Momentum on October 13, 2023
On October 16 2023 DexCom Inc was traded for 72.29 at the closing time. The highest daily price throughout the period was 72.29 and the lowest price was 72.29 . The daily volume was 40.0. The net trading volume on 10/16/2023 added to the next day price rise. The overall trading delta to closing price of the next trading day was 1.33% . The overall trading delta to current closing price is 14.62% . |
DexCom Inc Fundamentals Correlations and Trends
By evaluating DexCom's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among DexCom's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. DexCom financial account trend analysis is a perfect complement when working with valuation or volatility modules.About DexCom Stock history
DexCom investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for DexCom is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in DexCom Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing DexCom stock prices may prove useful in developing a viable investing in DexCom
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California. DEXCOM INC operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2800 people.
DexCom Stock Technical Analysis
DexCom technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
DexCom Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
DexCom Inc cannot be verified against its exchange. Please verify the symbol is currently traded on Frankfurt Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
DexCom December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how DexCom stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading DexCom shares will generate the highest return on investment. By undertsting and applying DexCom stock market strength indicators, traders can identify DexCom Inc entry and exit signals to maximize returns
DexCom Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for DexCom's price direction in advance. Along with the technical and fundamental analysis of DexCom Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of DexCom to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1026 | |||
Jensen Alpha | 0.2701 | |||
Total Risk Alpha | (0.06) | |||
Sortino Ratio | 0.1058 | |||
Treynor Ratio | (29.90) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for DexCom Stock analysis
When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |